Viewing Study NCT00185861


Ignite Creation Date: 2025-12-24 @ 12:11 PM
Ignite Modification Date: 2026-01-15 @ 4:14 AM
Study NCT ID: NCT00185861
Status: COMPLETED
Last Update Posted: 2009-04-09
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
Sponsor: Stanford University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: BRNCNS0001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Iris Catrice Gibbs, Principal Investigator
Old Organization: Stanford Univesity School of Medicine

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View